Boston Scientific Corp. (BSX)
49.01
-1.36
(-2.70%)
USD |
NYSE |
Aug 24, 16:00
49.03
+0.02
(+0.04%)
After-Hours: 20:00
Boston Scientific Total Liabilities (Quarterly) : 20.04B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.04B |
| March 31, 2026 | 18.25B |
| December 31, 2025 | 19.20B |
| September 30, 2025 | 19.08B |
| June 30, 2025 | 18.91B |
| March 31, 2025 | 17.70B |
| December 31, 2024 | 17.39B |
| September 30, 2024 | 17.12B |
| June 30, 2024 | 16.50B |
| March 31, 2024 | 16.50B |
| December 31, 2023 | 15.61B |
| September 30, 2023 | 14.91B |
| June 30, 2023 | 15.12B |
| March 31, 2023 | 14.78B |
| December 31, 2022 | 14.90B |
| September 30, 2022 | 14.31B |
| June 30, 2022 | 14.94B |
| March 31, 2022 | 15.60B |
| December 31, 2021 | 15.61B |
| September 30, 2021 | 15.42B |
| June 30, 2021 | 15.22B |
| March 31, 2021 | 15.18B |
| December 31, 2020 | 15.45B |
| September 30, 2020 | 15.28B |
| June 30, 2020 | 15.21B |
| Date | Value |
|---|---|
| March 31, 2020 | 16.31B |
| December 31, 2019 | 16.69B |
| September 30, 2019 | 17.06B |
| June 30, 2019 | 14.88B |
| March 31, 2019 | 14.57B |
| December 31, 2018 | 12.27B |
| September 30, 2018 | 12.09B |
| June 30, 2018 | 11.87B |
| March 31, 2018 | 12.17B |
| December 31, 2017 | 12.03B |
| September 30, 2017 | 11.05B |
| June 30, 2017 | 11.15B |
| March 31, 2017 | 10.89B |
| December 31, 2016 | 11.36B |
| September 30, 2016 | 11.22B |
| June 30, 2016 | 11.62B |
| March 31, 2016 | 11.26B |
| December 31, 2015 | 11.81B |
| September 30, 2015 | 11.80B |
| June 30, 2015 | 10.54B |
| March 31, 2015 | 9.971B |
| December 31, 2014 | 10.57B |
| September 30, 2014 | 10.02B |
| June 30, 2014 | 9.933B |
| March 31, 2014 | 9.801B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Abbott Laboratories | 57.45B |
| Becton, Dickinson & Co. | 26.31B |
| Penumbra, Inc. | 443.96M |
| Insulet Corp. | 1.743B |
| Intuitive Surgical, Inc. | 2.579B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.22B |
| Shareholders Equity (Quarterly) | 24.93B |
| Debt to Equity Ratio | 0.5064 |
| Current Ratio | 1.240 |
| Net Debt Paydown Yield | -0.30% |